Myocardial regeneration via cell cycle activation

Rebuilding the Infarcted Heart

Volumn , Issue , 2007, Pages 41-53

  LaFontant, Pascal J ^a   Field, Loren J ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84855483139     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (73)

1. Soonpaa MH, Field LJ. Survey of studies examining mammalian cardiomyocyte DNA synthesis. Circ Res 1998; 83: 15-26.
2. Anversa P, Kajstura J. Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ Res 1998; 83: 1-14.
3. Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest 2005; 115: 572-83.
4. Chien KR. Stem cells: lost in translation. Nature 2004; 428: 607-8.
5. Field LJ. Unraveling the mechanistic basis of mesenchymal stem cell activity in the heart. Mol Ther 2006; 14: 755-6.
6. Reinlib L, Field L. Cell transplantation as future therapy for cardiovascular disease?: A workshop of the National Heart, Lung, and Blood Institute. Circulation 2000; 101: E182-7.
7. Dowell JD, Rubart M, Pasumarthi KB, Soonpaa MH, Field LJ. Myocyte and myogenic stem cell transplantation in the heart. Cardiovasc Res 2003; 58: 336-50.
8. Kovacic JC, Muller DW, Graham RM. Actions and therapeutic potential of G-CSF and GM-CSF in cardiovascular disease. J Mol Cell Cardiol 2007; 42: 19-33.
9. Pasumarthi KB, Field LJ. Cardiomyocyte cell cycle regulation. Circ Res 2002; 90: 1044-54.
10. Rumyantsev PP. Interrelations of the proliferation and differentiation processes during cardiac myogenesis and regeneration. Int Rev Cytol 1977; 51: 186-273.
11. Oberpriller J, Oberpriller JC. Cell division in adult newt cardiac myocytes. In: Oberpriller J, Oberpriller JC, Maruro A, eds. The Development and Regenerative Potential of Cardiac Muscle. Chur: Harwood Academic Publishers, 1991: 293-312.
12. Oberpriller JO, Oberpriller JC. Response of the adult newt ventricle to injury. J Exp Zool 1974; 187: 249-53.
13. Bader D, Oberpriller JO. Repair and reorganization of minced cardiac muscle in the adult newt (Notophthalmus viridescens). J Morphol 1978; 155: 349-57.
14. Bader D, Oberpriller J. Autoradiographic and electron microscopic studies of minced cardiac muscle regeneration in the adult newt, notophthalmus viridescens. J Exp Zool 1979; 208: 177-93.
15. Bettencourt-Dias M, Mittnacht S, Brockes JP. Heterogeneous proliferative potential in regenerative adult newt cardiomyocytes. J Cell Sci 2003; 116: 4001-9.
16. Huang CJ, Jou TS, Ho YL et al. Conditional expression of a myocardium-specific transgene in zebrafish transgenic lines. Dev Dyn 2005; 233: 1294-303.
17. Mably JD, Chuang LP, Serluca FC et al. santa and valentine pattern concentric growth of cardiac myocardium in the zebrafish. Development 2006; 133: 3139-46.
18. Lien CL, Schebesta M, Makino S, Weber GJ, Keating MT. Gene expression analysis of zebrafish heart regeneration. PLoS Biol 2006; 4: e260.
19. Wang WD, Huang CJ, Lu YF et al. Heart-targeted overexpression of Nip3a in zebrafish embryos causes abnormal heart development and cardiac dysfunction. Biochem Biophys Res Commun 2006; 347: 979-87.
20. Poss KD, Wilson LG, Keating MT. Heart regeneration in zebrafish. Science 2002; 298: 2188-90.
21. Wei Y, Mizzen CA, Cook RG, Gorovsky MA, Allis CD. Phosphorylation of histone H3 at serine 10 is correlated with chromosome condensation during mitosis and meiosis in Tetrahymena. Proc Natl Acad Sci USA 1998; 95: 7480-4.
22. Raya A, Koth CM, Buscher D et al. Activation of Notch signaling pathway precedes heart regeneration in zebrafish. Proc Natl Acad Sci USA 2003; 100(Suppl 1): 11889-95.
23. Lepilina A, Coon AN, Kikuchi K et al. A dynamic epicardial injury response supports progenitor cell activity during zebrafish heart regeneration. Cell 2006; 127: 607-19.
24. Pelc SR. Labelling of DNA and cell division in so called non-dividing tissues. J Cell Biol 1964; 22: 21-8.
25. van Oijen MG, Medema RH, Slootweg PJ, Rijksen G. Positivity of the proliferation marker Ki-67 in noncycling cells. Am J Clin Pathol 1998; 110: 24-31.
26. Field LJ. Modulation of the cardiomyocyte cell cycle in genetically altered animals. Ann NY Acad Sci 2004; 1015: 160-70.
27. Engel FB, Schebesta M, Keating MT. Anillin localization defect in cardiomyocyte binucleation. J Mol Cell Cardiol 2006; 41: 601-12.
28. Soonpaa MH, Field LJ. Assessment of cardiomyocyte DNA synthesis during hypertrophy in adult mice. Am J Physiol 1994; 266: H1439-45.
29. Rumiantsev PP. Growth and Hyperplasia of Cardiac Muscle Cells. London: Harwood Academic Publishers, 1991.
30. Brodsky V. Cell ploidy in the mammalian heart. In: Oberpriller J, Oberpriller JC, Mauro A, eds. The Development and Regenerative Potential of Cardiac Muscle. Chur: Harwood Academic Publishers, 1991: 253-87.
31. Meckert PC, Rivello HG, Vigliano C et al. Endomitosis and polyploidization of myocardial cells in the periphery of human acute myocardial infarction. Cardiovasc Res 2005; 67: 116-23.
32. Oh H, Bradfute SB, Gallardo TD et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA 2003; 100: 12313-18.
33. Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 2003; 425: 968-73.
34. Anatskaya OV, Vinogradov AE. Paradoxical relationship between protein content and nucleolar activity in mammalian cardiomyocytes. Genome 2004; 47: 565-78.
35. Gulick J, Subramaniam A, Neumann J, Robbins J. Isolation and characterization of the mouse cardiac myosin heavy chain genes. J Biol Chem 1991; 266: 9180-5.
36. Soonpaa MH, Field LJ. Assessment of cardiomyocyte DNA synthesis in normal and injured adult mouse hearts. Am J Physiol 1997; 272: H220-6.
37. Soonpaa MH, Koh GY, Klug MG, Field LJ. Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science 1994; 264: 98-101.
38. Nakajima H, Nakajima HO, Tsai SC, Field LJ. Expression of mutant p193 and p53 permits cardiomyocyte cell cycle reentry after myocardial infarction in transgenic mice. Circ Res 2004; 94: 1606-14.
39. Pasumarthi KB, Nakajima H, Nakajima HO, Soonpaa MH, Field LJ. Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice. Circ Res 2005; 96: 110-18.
40. Matsuura K, Wada H, Nagai T et al. Cardiomyocytes fuse with surrounding noncardiomyocytes and reenter the cell cycle. J Cell Biol 2004; 167: 351-63.
41. Soonpaa MH, Koh GY, Pajak L et al. Cyclin D1 overexpression promotes cardiomyocyte DNA synthesis and multinucleation in transgenic mice. J Clin Invest 1997; 99: 2644-54.
42. Tamamori-Adachi M, Ito H, Sumrejkanchanakij P et al. Critical role of cyclin D1 nuclear import in cardiomyocyte proliferation. Circ Res 2003; 92: e12-19.
43. Hassink RJ, Pasumarthi KB, Nakajima H et al. Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarction. Submitted.
44. Nakajima H, Nakajima HO, Dembowsky K, Pasumarthi KB, Field LJ. Cardiomyocyte cell cycle activation ameliorates fibrosis in the atrium. Circ Res 2006; 98: 141-8.
45. Petrich BG, Wang Y. Stress-activated MAP kinases in cardiac remodeling and heart failure; new insights from transgenic studies. Trends Cardiovasc Med 2004; 14: 50-5.
46. Kaiser RA, Lyons JM, Duffy JY et al. Inhibition of p38 reduces myocardial infarction injury in the mouse but not pig after ischemia-reperfusion. Am J Physiol Heart Circ Physiol 2005; 289: H2747-51.
47. Kaiser RA, Bueno OF, Lips DJ et al. Targeted inhibition of p38 mitogen-activated protein kinase antagonizes cardiac injury and cell death following ischemia-reperfusion in vivo. J Biol Chem 2004; 279: 15524-30.
48. Engel FB, Schebesta M, Duong MT et al. p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev 2005; 19: 1175-87.
49. Claycomb WC, Moses RL. Growth factors and TPA stimulate DNA synthesis and alter the morphology of cultured terminally differentiated adult rat cardiac muscle cells. Dev Biol 1988; 127: 257-65.
50. Engel FB, Hsieh PC, Lee RT, Keating MT. FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction. Proc Natl Acad Sci USA 2006; 103: 15546-51.
51. Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 1995; 9: 1149-63.
52. Pagano M, Pepperkok R, Verde F, Ansorge W, Draetta G. Cyclin A is required at two points in the human cell cycle. EMBO J 1992; 11: 961-71.
53. Chaudhry HW, Dashoush NH, Tang H et al. Cyclin A2 mediates cardiomyocyte mitosis in the postmitotic myocardium. J Biol Chem 2004; 279: 35858-66.
54. Woo YJ, Panlilio CM, Cheng RK et al. Therapeutic delivery of cyclin A2 induces myocardial regeneration and enhances cardiac function in ischemic heart failure. Circulation 2006; 114: I206-13.
55. Field LJ. Atrial natriuretic factor-SV40 T antigen transgenes produce tumors and cardiac arrhythmias in mice. Science 1988; 239: 1029-33.
56. Behringer RR, Peschon JJ, Messing A et al. Heart and bone tumors in transgenic mice. Proc Natl Acad Sci USA 1988; 85: 2648-52.
57. Katz EB, Steinhelper ME, Delcarpio JB et al. Cardiomyocyte proliferation in mice expressing alpha-cardiac myosin heavy chain-SV40 T-antigen transgenes. Am J Physiol 1992; 262: H1867-76.
58. Daud AI, Lanson NA Jr, Claycomb WC, Field LJ. Identification of SV40 large T-antigen-associated proteins in cardiomyocytes from transgenic mice. Am J Physiol 1993; 264: H1693-H1700.
59. Tsai SC, Pasumarthi KB, Pajak L et al. Simian virus 40 large T antigen binds a novel Bcl-2 homology domain 3-containing proapoptosis protein in the cytoplasm. J Biol Chem 2000; 275: 3239-46.
60. Dias DC, Dolios G, Wang R, Pan ZQ. CUL7: a DOC domain-containing cullin selectively binds Skp1.Fbx29 to form an SCF-like complex. Proc Natl Acad Sci USA 2002; 99: 16601-6.
61. Pasumarthi KB, Tsai SC, Field LJ. Coexpression of mutant p53 and p193 renders embryonic stem cell-derived cardiomyocytes responsive to the growth-promoting activities of adenoviral E1A. Circ Res 2001; 88: 1004-11.
62. MacLellan WR, Garcia A, Oh H et al. Overlapping roles of pocket proteins in the myocardium are unmasked by germ line deletion of p130 plus heart-specific deletion of Rb. Mol Cell Biol 2005; 25: 2486-97.
63. Jackson T, Allard MF, Sreenan CM et al. The c-myc proto-oncogene regulates cardiac development in transgenic mice. Mol Cell Biol 1990; 10: 3709-16.
64. Xiao G, Mao S, Baumgarten G et al. Inducible activation of c-Myc in adult myocardium in vivo provokes cardiac myocyte hypertrophy and reactivation of DNA synthesis. Circ Res 2001; 89: 1122-9.
65. Pasumarthi KB, Nakajima H, Nakajima HO, Jing S, Field LJ. Enhanced cardiomyocyte DNA synthesis during myocardial hypertrophy in mice expressing a modified TSC2 transgene. Circ Res 2000; 86: 1069-77.
66. Limana F, Urbanek K, Chimenti S et al. bcl-2 overexpression promotes myocyte proliferation. Proc Natl Acad Sci USA 2002; 99: 6257-62.
67. Reiss K, Cheng W, Ferber A et al. Overexpression of insulin-like growth factor-1 in the heart is coupled with myocyte proliferation in transgenic mice. Proc Natl Acad Sci USA 1996; 93: 8630-5.
68. Liao HS, Kang PM, Nagashima H et al. Cardiacspecific overexpression of cyclin-dependent kinase 2 increases smaller mononuclear cardiomyocytes. Circ Res 2001; 88: 443-50.
69. Brodsky V, Sarkisov DS, Arefyeva AM, Panova NW, Gvasava IG. Polyploidy in cardiac myocytes of normal and hypertrophic human hearts; range of values. Virchows Arch 1994; 424: 429-35.
70. Beltrami AP, Urbanek K, Kajstura J et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001; 344: 1750-7.
71. Ebert L, Pfitzer P. Nuclear DNA of myocardial cells in the periphery of infarctions and scars. Virchows Arch B Cell Pathol 1977; 24: 209-17.
72. Herget GW, Neuburger M, Plagwitz R, Adler CP. DNA content, ploidy level and number of nuclei in the human heart after myocardial infarction. Cardiovasc Res 1997; 36: 45-51.
73. Hein S, Arnon E, Kostin S et al. Progression from compensated hypertrophy to failure in the pressureoverloaded human heart: structural deterioration and compensatory mechanisms. Circulation 2003; 107: 984-91.